Source: Annual Congress 2006 - Clinical features of interstitial lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Furonaka, N. Hattori, T. Tanimoto, A. Yokoyama, N. Kohno (Hiroshima, Japan). Effect of suplatast tosilate on bleomycin-induced lung fibrosis in mice. Eur Respir J 2006; 28: Suppl. 50, 1762

Member's Comments

No comment yet.

Related content which might interest you: Anti-fibrotic effect of telmisartan on bleomycin-induced lung fibrosis in mice Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Effect of nintedanib on silica-induced lung inflammation and fibrosis in mice Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Effect of NF-?B inhibitor IMD-1041 on BLM-induced pulmonary fibrosis in mice Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Enhanced lung inflammatory response to intratracheal CpG-ODN in mice with bleomycin-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 The effect of pravastatin on bleomycin-induced lung injury and fibrosis in mouse Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 Rikkunshito ameliorates bleomycin-induced lung injury in mice Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Olodaterol attenuates bleomycin induced lung fibrosis in mice Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Antifibrotic effects of Lck inhibition on bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 A comparison of suplatast tosilate, a Th2 cytokine inhibitor, and inhaled fluticasone propionate for airway inflammation in mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 373s Year: 2002 Anti-inflammatory and anti-fibrotic effects of sirolimus in bleomycin-induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Effect of simvastatin on bleomycin induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005 Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats Source: Eur Respir J 2003 Dec 01;22(6):900-905 Year: 2003 Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats Source: Eur Respir J 2001; 17: 1228-1235 Year: 2001 The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2002; 20: Suppl. 38, 487s Year: 2002 Therapeutic effect of combination of salvia and ligustrazine on bleomycin-induced pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011